Johnson & Johnson announces new Phase 2 nipocalimab study data in Sjögren's disease that reveal insights on importance of symptom improvements most valued by patients

The Quick Take
New patient experience dataa to be presented at ACR 2026 show mouth dryness was reported as the most important symptom to improve, followed by eye dryness, fatigue and joint pain Patient insights complement Phase 2 study results demonstrating a 50% increase in saliva productionb in more...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire General Business.
Related
Business
Off-Broadway Production DUST Raises $30,000 for Young Adults with Autism
LOS ANGELES, Nov. 7, 2026 /PRNewswire/ -- The Off-Broadway production DUST raised $30,000 to support young adults with autism in partnership with Cultural…
Business
Clough Global Opportunities Fund director buys $1,996 in GLO shares
Business
How #Amazon's low prices raises #prices. #soexpensive
------------------------------------------------------ Business Insider is a global newsroom covering business, technology, innovation, and the economy. Visit…
Business
